FDA asked to consider Cymbalta for chronic pain

Drugmaker Eli Lilly & Co. has asked the U.S. Food and Drug Administration to approve Cymbalta for the management of chronic pain. Lilly's supplemental new drug application is based on clinical trials in which Cymbalta was found effective at treating chronic osteoarthritis and lower back pain. Cymbalta is already approved in the United States for the treatment of major depressive disorder, generalized anxiety disorder, and diabetic neuropathy in adults.

(CNN Money) UPDATED 05/29/2008
Click here to read the full story
Conditions: | back pain - 26 Articles | chronic pain - 272 Articles | osteoarthritis (OA) - 226 Articles Treatments: | Cymbalta - 21 Articles
Helpful?
YesNo 




Navigation

Member Picks
Three vitamin supplements reflux sufferers may need
View Full Story
Chronic pain harms the brain
View Full Story
Research your meds on the Treatments tab
View Full Story
Caffeine could spell trouble for diabetics
View Full Story